Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 272-729-4 | CAS number: 68910-05-4 A complex residuum from the fractionation of the reaction products of 2-aminoethanol with ammonia to remove piperazine. It may contain such compounds as 2-[(2-aminoethyl)amino]ethanol, (aminoethyl)piperazine, (hydroxyethyl)piperazine.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comparable to guideline study with acceptable restrictions. Original reference in Japanese, study summary and tables in English.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- yes
- Remarks:
- Samples of bone marrow were taken onle once (24 h).
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 2-(2-aminoethylamino)ethanol
- EC Number:
- 203-867-5
- EC Name:
- 2-(2-aminoethylamino)ethanol
- Cas Number:
- 111-41-1
- Molecular formula:
- C4H12N2O
- IUPAC Name:
- 2-[(2-aminoethyl)amino]ethanol
- Details on test material:
- - Name of test material (as cited in study report): N-(Aminoethyl)ethanolamin (AEEA)
- Analytical purity: 99.9 %
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- other: Crj:BDF1
- Sex:
- male/female
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - solvent used: water
- Duration of treatment / exposure:
- - animals received single doses of AEEA dissolved in water
- Post exposure period:
- - 24 hours after dosing the animals were killed
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0; 500; 1000; 2000 mg/kg bw
Basis:
other: gavage
- No. of animals per sex per dose:
- 5
- Control animals:
- other: solvent
- Positive control(s):
- - Cyclophosphamide
- Route of administration: oral per gavage
- Concentration: 50 mg/kg bw
Examinations
- Tissues and cell types examined:
- - Bone marrow blood cells were prepared
- Details of tissue and slide preparation:
- DETAILS OF SLIDE PREPARATION:
- Bone marrow blood cells were prepared, stained (acridine orange), and analysed for the occurrence of micronucleated polychromatic
erythrocytes (MNPCE)
METHOD OF ANALYSIS:
- 2000 polychromatic erythrocytes (PCE) per animal counted
- The proportion of polychromatic erythrocytes in 500 erythrocytes was also recorded(PCE/500 ERY)
- results were expressed as percentage of MNPCE/PCE and the percentage of PCE/ERY. - Statistics:
- A statistical evaluation was performed. The method applied is not known because it is not described in the English section of the paper.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
Any other information on results incl. tables
The percentage of micronucleated cells per 2000
polychromatic cells, and the percentage of polychromatic cells per 500
erythrocytes was as follows (means +/- SD):
Group |
% MNPCE/PCE |
% PCE/ERY |
|
|
|
Solvent |
0.19 ± 0.05 |
55.5 ± 5.5 |
|
|
|
AEEA |
|
|
500 mg/kg bw |
0.19 ± 0.10 |
55.3 ± 3.6 |
1000 mg/kg bw |
0.11 ± 0.04 |
57.0 ± 5.3 |
2000 mg/kg bw |
0.23 ± 0.14 |
51.5 ± 3.9 |
|
|
|
Pos. Control: CPA 50 mg/kg bw |
1.82 ± 0.43 *** |
48.7 ± 2.7 |
MNPCE: micronucleated polychromatic
erythrocytes
PCE: polychromatic erythrocytes
*** = p < 0 .001 compared to the solvent control
The frequency of micronucleated immature erythrocytes was not significantly increased in males or females up to the dose of 2000 mg/kg bw by oral gavage and animals killed after 24 h after treatment. Inhibition of bone marrow cell proliferation was not observed under the test conditions.
Applicant's summary and conclusion
- Executive summary:
In a Crj:BDF1 mouse bone marrow micronucleus assay 5 animals/sex/dose were treated by gavage with AEEA (99.9 % a.i.) at doses of 0, 500, 1000, or 2000 mg/kg bw. Bone marrow cells were harvested 24 hours post-treatment. The vehicle was water.
There were no signs of toxicity during the study. The positive control (CPA) induced the appropriate response. There was not a significant increase in the frequency of micronucleated polychromatic erythrocytes in bone marrow up to the dose of 2000 mg/kg bw after treatment time.
This study is classified as acceptable and satisfies the requirement for Test Guideline OECD 474 for in vivo cytogenetic mutagenicity data.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.